Surendra K. Ajjarapu - Jan 5, 2024 Form 4 Insider Report for TRxADE HEALTH, INC (MEDS)

Role
Chairman and CEO, Director
Signature
/s/ Surendra Ajjarapu
Stock symbol
MEDS
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
4
Date filed
1/16/2024, 06:10 AM
Previous filing
Aug 28, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDS Common stock Award $0 +150K $0.00 150K Jan 5, 2024 By Sandhya Ajjarapu Revocable Trust 2007 F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/2 of the shares on January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as an officer of the Company.
F3 These securities are owned directly by the Sandhya Trust, of which Mr. Ajjarapu is the trustee. Mr. Ajjarapu, as the trustee, is deemed to have indirect beneficial ownership of the shares held by the Sandhya Trust.